Literature DB >> 3179137

A comparison of sympathoadrenal activity and cardiac performance at rest and during exercise in patients with ventricular demand or atrial synchronous pacing.

S K Pehrsson1, P Hjemdahl, R Nordlander, H Aström.   

Abstract

Cardiac sympathetic function was assessed by measuring the coronary sinus overflow of noradrenaline and dopamine at rest and during supine exercise in eight patients with high degree atrioventricular block treated with dual chamber pacemakers (DDD). Patients exercised (30-60 W) during both ventricular inhibited (VVI) and atrial synchronous (VAT) pacing. During exercise cardiac output increased less markedly in the VVI mode than in the VAT mode. The cardiac output response was entirely stroke volume dependent in the VVI mode and mainly heart rate dependent in the VAT mode. Coronary sinus noradrenaline concentrations were higher in the VVI mode at rest and during exercise. Noradrenaline overflow from the heart was enhanced during VVI pacing and increased from about 100 pmol/min (17 ng/min) at rest to 1087 pmol/min during exercise (60 W) in the VVI mode and 545 pmol/min in the VAT mode. Dopamine overflow from the heart was less than 5 pmol/at rest but increased 2-5 fold during exercise. Also arterial concentrations of catecholamine increased more during exercise in the VVI mode, but the differences between pacing modes were less pronounced. Circulating adrenaline seems to be of little importance for cardiac function under these conditions; in healthy individuals the arterial concentrations of adrenaline attained in this study have small effects. Cardiac noradrenaline overflow correlated with pulmonary capillary venous pressures and atrial rates in both pacing modes, indicating a relation between cardiac sympathetic activity and cardiac function. Enhanced cardiac release of noradrenaline may increase cardiac contractility and thereby partially compensate for the lack of heart rate responsiveness to exercise during VVI pacing.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3179137      PMCID: PMC1216556          DOI: 10.1136/hrt.60.3.212

Source DB:  PubMed          Journal:  Br Heart J        ISSN: 0007-0769


  32 in total

1.  Left ventricular volumes with ventricular inhibited and atrial triggered ventricular pacing.

Authors:  S K Pehrsson; H Aström; D Bone
Journal:  Acta Med Scand       Date:  1983

2.  Heart rate modulates the disposition of neurally released norepinephrine in cardiac tissues.

Authors:  Y Masuda; M N Levy
Journal:  Circ Res       Date:  1985-07       Impact factor: 17.367

3.  Differentiated sympathetic activation during mental stress evoked by the Stroop test.

Authors:  P Hjemdahl; U Freyschuss; A Juhlin-Dannfelt; B Linde
Journal:  Acta Physiol Scand Suppl       Date:  1984

4.  Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure.

Authors:  J N Cohn; T B Levine; M T Olivari; V Garberg; D Lura; G S Francis; A B Simon; T Rector
Journal:  N Engl J Med       Date:  1984-09-27       Impact factor: 91.245

5.  Left ventricular function after long-term treatment with ventricular inhibited compared to atrial triggered ventricular pacing.

Authors:  S K Pehrsson; H Aström
Journal:  Acta Med Scand       Date:  1983

6.  Contribution of individual organs to total noradrenaline release in humans.

Authors:  M Esler; G Jennings; P Leonard; N Sacharias; F Burke; J Johns; P Blombery
Journal:  Acta Physiol Scand Suppl       Date:  1984

7.  Norepinephrine spillover to plasma in patients with congestive heart failure: evidence of increased overall and cardiorenal sympathetic nervous activity.

Authors:  G J Hasking; M D Esler; G L Jennings; D Burton; J A Johns; P I Korner
Journal:  Circulation       Date:  1986-04       Impact factor: 29.690

8.  Further studies on renal nerve stimulation induced release of noradrenaline and dopamine from the canine kidney in situ.

Authors:  T Bradley; P Hjemdahl
Journal:  Acta Physiol Scand       Date:  1984-11

9.  Elevated left ventricular myocardial dopamine in preterminal idiopathic dilated cardiomyopathy.

Authors:  G L Pierpont; G S Francis; E G DeMaster; T B Levine; R M Bolman; J N Cohn
Journal:  Am J Cardiol       Date:  1983-11-01       Impact factor: 2.778

Review 10.  Dopamine: an important neurohormone of the sympathoadrenal system. Significance of increased peripheral dopamine release for the human stress response and hypertension.

Authors:  S R Snider; O Kuchel
Journal:  Endocr Rev       Date:  1983       Impact factor: 19.871

View more
  7 in total

Review 1.  Cardiac pacing in patients with dilated cardiomyopathy.

Authors:  F M Kusumoto; N Goldschlager
Journal:  J Interv Card Electrophysiol       Date:  1997-09       Impact factor: 1.900

2.  Heart rate and catecholamine contribution to QT interval shortening on exercise.

Authors:  P Davey; J Bateman
Journal:  Clin Cardiol       Date:  1999-08       Impact factor: 2.882

3.  Double blind crossover comparison of the effects of dual chamber pacing (DDD) and ventricular rate adaptive (VVIR) pacing on neuroendocrine variables, exercise performance, and symptoms in complete heart block.

Authors:  K G Oldroyd; A P Rae; R Carter; C Wingate; S M Cobbe
Journal:  Br Heart J       Date:  1991-04

4.  Electrocardiographic abnormalities of takotsubo cardiomyopathy in a patient with paced ventricular rhythm.

Authors:  Krati Chauhan; Siva P Sontineni; Venkata M Alla; Mark J Holmberg
Journal:  Cardiol Res Pract       Date:  2010-06-08       Impact factor: 1.866

5.  Sensors for rate responsive pacing.

Authors:  Simonetta Dell'Orto; Paolo Valli; Enrico Maria Greco
Journal:  Indian Pacing Electrophysiol J       Date:  2004-07-01

6.  Chronotropic incompetence in Chagas disease: usefulness of dual sensor pacemaker based on volume minute and accelerometer.

Authors:  José Carlos Pachón
Journal:  Rev Bras Cir Cardiovasc       Date:  2015 Jul-Sep

Review 7.  Dual chamber versus single chamber ventricular pacemakers for sick sinus syndrome and atrioventricular block.

Authors:  J Dretzke; W D Toff; G Y H Lip; J Raftery; A Fry-Smith; R Taylor
Journal:  Cochrane Database Syst Rev       Date:  2004
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.